146 related articles for article (PubMed ID: 30897918)
1. Differentiating Parkinson's disease from drug-induced Parkinsonism.
Wearne D; McCarthy M; Orr C
Aust N Z J Psychiatry; 2019 Sep; 53(9):923-924. PubMed ID: 30897918
[No Abstract] [Full Text] [Related]
2. [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.
Brigo F; Matinella A; Erro R; Tinazzi M
Eur J Neurol; 2014 Nov; 21(11):1369-e90. PubMed ID: 24779862
[TBL] [Abstract][Full Text] [Related]
3. Is transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?
Mahlknecht P; Stockner H; Kiechl S; Willeit J; Rastner V; Gasperi A; Rungger G; Poewe W; Seppi K
Mov Disord; 2012 Aug; 27(9):1194-6. PubMed ID: 22692761
[No Abstract] [Full Text] [Related]
4. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
Yomtoob J; Koloms K; Bega D
Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
[No Abstract] [Full Text] [Related]
6. DAT imaging in drug-induced and psychogenic parkinsonism.
Tolosa E; Coelho M; Gallardo M
Mov Disord; 2003 Oct; 18 Suppl 7():S28-33. PubMed ID: 14531043
[TBL] [Abstract][Full Text] [Related]
7. Clozapine as a diagnostic tool for a psychotic parkinsonian patient.
Frye MA; Wirshing WC; Ames D
J Clin Psychopharmacol; 1993 Oct; 13(5):359-60. PubMed ID: 7901246
[No Abstract] [Full Text] [Related]
8. Drug-induced parkinsonism.
Lancet; 1985 Jan; 1(8420):113. PubMed ID: 2857014
[No Abstract] [Full Text] [Related]
9. Not Parkinson's disease.
Lancet; 1982 Jul; 2(8288):49. PubMed ID: 6123781
[No Abstract] [Full Text] [Related]
10. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
Hausner RS
J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
[TBL] [Abstract][Full Text] [Related]
11. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
[TBL] [Abstract][Full Text] [Related]
12. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?
Melamed E; Achiron A; Shapira A; Davidovicz S
Clin Neuropharmacol; 1991 Jun; 14(3):273-8. PubMed ID: 1676933
[TBL] [Abstract][Full Text] [Related]
13. Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
Schuster JP; Buhl C; Archambaud F; Hardy P; Chouinard G; Prigent A; Corruble E
Psychiatry Clin Neurosci; 2007 Apr; 61(2):206. PubMed ID: 17362445
[No Abstract] [Full Text] [Related]
14. Ethosuximide and tremor in Parkinson's disease: a pilot study.
Pourcher E; Gomez-Mancilla B; Bédard PJ
Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Hardie RJ; Lees AJ
J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):850-4. PubMed ID: 2900293
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced Parkinsonism and idiopathic Parkinson's disease.
Goetz CG
Arch Neurol; 1983 May; 40(5):325-6. PubMed ID: 6133514
[No Abstract] [Full Text] [Related]
17. Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.
Morley JF; Duda JE
J Parkinsons Dis; 2014; 4(2):169-73. PubMed ID: 24284418
[TBL] [Abstract][Full Text] [Related]
18. Hand deformities in extrapyramidal disorders.
Di Petta G; Del Puente A; Scarpa R; Maglione S; Esposito del Puente A; Campanella G
Acta Neurol (Napoli); 1994 Jun; 16(3):142-6. PubMed ID: 7992664
[TBL] [Abstract][Full Text] [Related]
19. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
Friis T; Christensen TR; Gerlach J
Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
[No Abstract] [Full Text] [Related]
20. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
Oh YS; Kwon DY; Kim JS; Park MH; Berg D
Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
